Accuray Incorporated (ARAY) News

Accuray Incorporated (ARAY): $4.47

-0.06 (-1.32%)

POWR Rating

Component Grades













Filter ARAY News Items

ARAY News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

ARAY News Highlights

  • ARAY's 30 day story count now stands at 4.
  • Over the past 8 days, the trend for ARAY's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
  • The most mentioned tickers in articles about ARAY are LUNG, BEAM and EBS.

Latest ARAY News From Around the Web

Below are the latest news stories about Accuray Inc that investors may wish to consider to help them evaluate ARAY as an investment opportunity.

New Strong Sell Stocks for April 30th

ARAY, EBS, FARM, SHLX, and TPB have been added to the Zacks Rank #5 (Strong Sell) List on April 30, 2021

Yahoo | April 30, 2021

Accuray Customers Achieve Top Scores in AAPM MArkerless Lung Target Tracking CHallenge (MATCH) Using Synchrony® Technology on the Radixact® and CyberKnife® Systems

Accuray Incorporated (NASDAQ: ARAY) announced today that Accuray customers took the top two positions in the MArkerless Lung Target Tracking CHallenge (MATCH) experimental branch using the Accuray Synchrony Lung Tracking with Respiratory Modeling on the Radixact® next-generation TomoTherapy® platform, and CyberKnife® System, respectively. The artificial intelligence (AI)-driven Synchrony technology is unique in using image guidance during radiation treatment delivery to detect motion and automatically adapt and synchronize radiation treatment in real-time with the movement of the target.

Yahoo | April 29, 2021

Accuray's (ARAY) CEO Josh Levine on Q3 2021 Results - Earnings Call Transcript

Accuray Incorporated (ARAY) Q3 2021 Earnings Conference Call April 27, 2021 4:30 PM ET Company Participants Ken Mobeck – Vice President-Finance and Investor Relations Josh Levine – President and Chief Executive Officer Shig Hamamatsu – Senior Vice President and Chief Financial Officer Suzanne Winter – Senior Vice President-Research and Development...

SA Transcripts on Seeking Alpha | April 28, 2021

Accuray Receives Shonin Approval for ClearRT™ Helical kVCT Imaging, CE Mark Expected by End of June; Expands Commercial Launch

Accuray Incorporated (NASDAQ: ARAY) announced today that the innovative ClearRT™ helical fan-beam kVCT imaging* capability has now been in clinical use for over two months, and is on track to expand into other markets. ClearRT on the Radixact® System is believed to have the potential to change the field of radiation oncology by enabling clinicians to easily, quickly and cost effectively acquire diagnostic-like quality CT images that enable them to "See More, Know More, and Do More," when treating tumors with radiation.

Yahoo | April 22, 2021

Bone Cancer Market With Key Players like Novartis AG, Pfizer, Bayer AG, Takeda Pharmaceutical Company, Johnson and Johnson, Eli Lilly and Company, BD, Accuray Incorporated, Bristol-Myers Squibb Company, Merck & Co. Inc.

Bone cancer is diagnosed when there is abnormal cell growth in the bone and it tends to destroy bone tissue. It is a rare type of cancer in adults however, it may spread to lungs. The beast treatment option for

OpenPR | March 3, 2021

Accuray to Participate in BTIG's Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference

SUNNYVALE, Calif., Feb. 5, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today announced its participation in BTIG's Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference. The management team is scheduled to participate in a Fireside Chat on Thursday,…

PR Newswire | February 5, 2021

Accuray Reports Second Quarter Fiscal 2021 Financial Results

SUNNYVALE, Calif., Jan. 27, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported its financial results for the second quarter of fiscal 2021 ended December 31, 2020. Second Quarter Fiscal 2021 Summary Net revenue of $97.5 million including $21.3 million of system…

PR Newswire | January 27, 2021

Robotic Surgery Systems Market – Global Industry Analysis, Trends, Production, Revenue, Gross Margin Analysis and Forecast 2021-2027|Key Top Players- Intuitive Surgical,Inc., Computer Motion,Inc., Integrated Surgical, Stryker, Accuray, Medrobotics, Tita the exclusive leading provider of market research reports published research report on “Global Robotic Surgery Systems Market Research Report 2021”. The Global Robotic Surgery Systems Market Report 2021 is a professional and in-depth study on the current state of the

OpenPR | January 25, 2021

Surgical Robots Market: the government of India announced a US$ 9.87 billion outlay for the health sector | Key Players: Intuitive Surgical, Accuray Incorporated, Stryker, MEDTRONIC, Smith & Nephew

A type of minimally invasive surgery that uses robotics to perform surgical procedures is robotic surgery. These robotic systems are operated by surgeons and consist of miniaturized surgical instruments placed on robotic arms, enabling surgeons to precisely conduct the operations.

OpenPR | January 21, 2021

Accuray (ARAY) Scheduled to Post Quarterly Earnings on Wednesday

Accuray (NASDAQ:ARAY) is scheduled to issue its quarterly earnings data after the market closes on Wednesday, January 27th. Analysts expect the company to announce earnings of ($0.01) per share for the quarter. Parties interested in registering for the company’s conference call can do so using this link. Shares of ARAY stock opened at $4.76 on […]

Transcript Daily | January 20, 2021

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.6367 seconds.